Regulation of G protein-coupled receptor kinase 2 in brains of opiate- treated rats and human opiate addicts

Journal of Neurochemistry

Volumn 70, Issue 3, 1998, Pages 1249-1257

  Ozaita, Andrés ^a   Escribá, Pablo V ^a   Ventayol, Pere ^a   Murga, Cristina ^b   Mayor Jr , Federico ^b   García Sevilla, Jesús A ^a  

^a UNIVERSITAT DE LES ILLES BALEARS   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

G protein coupled receptor kinase; Human and rat brains; Immunoblotting; Morphine methadone; Opiate addiction

Indexed keywords

ALCOHOL; ALPHA TUBULIN; BENZODIAZEPINE; CANNABINOID; CHLOROQUINE; COCAINE; CODEINE; DRUG METABOLITE; GUANINE NUCLEOTIDE BINDING PROTEIN; METHADONE; METHAQUALONE; MORPHINE; NALOXONE; PROTEIN SERINE THREONINE KINASE; THIORIDAZINE; TRICHLOROETHANOL;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG DEPENDENCE; DRUG WITHDRAWAL; ENZYME ACTIVATION; FEMALE; FRONTAL CORTEX; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NEUROTRANSMISSION; NONHUMAN; OPIATE ADDICTION; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION;

ANIMALIA;

EID: 0031892145     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.70031249.x     Document Type: Article

References (57)

1. Aloyo V.J. (1994) Modulation of mu opioid binding by protein kinase inhibitors. Biochem. Pharmacol. 49, 17-21.
2. Arden J. R., Segredo V., Wang Z., Lameh J., and Sadée W. (1995) Phosphorylation and agonist-specific intracellular trafficking of an epitope-tagged μ-opioid receptor expressed in HEK 293 cells. J. Neurochem. 65, 1636-1645.
3. Arriza J. L., Dawson D. L., Simerly R. B., Martin L. J., Caron M. G., Snyder S. H., and Lefkowitz R. J. (1992) The G-protein-coupled receptor kinase beta ARK1 and beta ARK2 are widely distributed at synapses in the rat brain. J. Neurosci. 12, 4045-4055.
4. Benovic J. L., Strasser R. H., Caron M. G., and Lefkowitz R. J. (1986) β-Adrenergic receptor kinase: identification of a novel protein kinase that phosphorylates the agonist occupied form of the receptor. Proc. Natl. Acad. Sci. USA 83, 2797-2801.
5. 2-adrenergic receptor kinase. J. Biol. Chem. 262, 17251-17253.
6. Benovic J. L., Onorato J. J., Arriza J. L., Stone W. C., Lohse M., Jenkins N., Gilbert D. J., Copeland N. G., Caron M. G., and Lefkowitz R. J. (1991) Cloning, expression, and chromosomal localization of beta-adrenergic receptor kinase 2. A new member of the receptor kinase family. J. Biol. Chem. 266, 14939-14946.
7. Birnbaumer L. (1990) G proteins in signal transduction. Annu. Rev. Pharmacol. Toxicol. 30, 675-705.
8. Böhm S. K., Grady E. F., and Bunnett N. W. (1997) Regulatory mechanisms that modulate signalling by G-protein-coupled receptors. Biochem. J. 322, 1-18.
9. Bradford M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-272.
10. 2a-adrenoceptor mRNA in brain. Mol. Brain Res. 45, 154-158.
11. + channel. J. Biol. Chem. 269, 7839-7842.
12. Chen Y., Mestek A., Liu J., Harley J. A., and Yu L. (1993) Molecular cloning and functional expression of a μ-opioid receptor from rat brain. Mol. Pharmacol. 44, 8-12.
13. Chuang T. T., Lacovelli L., Sallese M., and De Blasi A. (1996) G protein-coupled receptors: heterologous regulation of homologous desensitization and its implications. Trends Pharmacol. Sci. 17, 416-421.
14. Cox B. (1990) Drug tolerance and physical dependence, in Principles of Drug Action (Pratt W. B. and Taylor P., eds), pp. 639-690. Churchill Livingstone, New York.
15. DeBlasi A., Parruti G., and Sallese M. (1995) Regulation of G protein-coupled receptor kinase subtypes in activated T lymphocytes. Selective increase of β-adrenergic receptor kinases 1 and 2. J. Clin. Invest. 95, 203-210.
16. Escribá P. V., Sastre M., and García-Sevilla J. A. (1994) Increased density of guanine nucleotide-binding proteins in the postmortem brain of heroin addicts. Arch. Gen. Psychiatry 51, 494-501.
17. 2-adrenoceptors in the rat brain: up-regulation of receptors associated with increased receptor appearance. J. Neurochem. 64, 2590-2597.
18. García-Higuera I., Penela P., Murga C., Egea G., Bonay P., Benovic J. L., and Mayor F. Jr. (1994) Association of the regulatory β-adrenergic receptor kinase with rat liver microsomal membranes. J. Biol. Chem. 269, 1348-1355.
19. 2-adrenoceptors in heroin addicts during withdrawal and after treatment with clonidine. Eur. J. Pharmacol. 114, 365-374.
20. 2-Adrenoceptor-mediated inhibition of platelet adenylate cyclase activity in heroin addicts in abstinence. Psychopharmacology (Berlin) 92, 320-323.
21. García-Sevilla J. A., Ventayol P., Busquets X., La Harpe R., Walzer C., and Guimón J. (1997a) Marked decrease of immunolabelled 68 kDa neurofilament (NF-L) proteins in brains of opiate addicts. Neuroreport 8, 1561-1570.
22. García-Sevilla J. A., Ventayol P., Busquets X., La Harpe R., Walzer C., and Guimón J. (1997b) Regulation of immunolabelled μ-opioid receptors and protein kinase C-α and ζ isoforms in the frontal cortex of human opiate addicts. Neurosci. Lett. 226, 29-32.
23. 2-adrenergic receptor. Nature 383, 447-450.
24. Gros R., Benovic J. L., Tan C. M., and Feldman R. D. (1997) G-protein-coupled receptor kinase activity is increased in hypertension. J. Clin. Invest. 99, 2087-2093.
25. Haga T., Haga K., and Kameyama K. (1994) G protein-coupled receptor kinases. J. Neurochem. 63, 400-412.
26. Harlow E. and Lane D. (1988) Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York.
27. Inglese J., Koch W. J., Caron M. G., and Lefkowitz R. J. (1993) Structure and mechanism of G protein-coupled receptor kinases. J. Biol. Chem. 268, 23735-23738.
28. Keith D. E., Murray S. R., Zaki P. A., Chu P. C., Lissin D. V., Kang L., Evans C. J., and von Zastrow M. (1996) Morphine activates opioid receptors without causing their rapid internalization. J. Biol. Chem. 271, 19021-19024.
29. Koch W. J., Rockman H. A., Samama P., Hamilton R. A., Bond R. A., Milano C. A., and Lefkowitz R. J. (1995) Cardiac function in mice overexpressing the β-adrenergic receptor kinase or a βARK inhibitor. Science 268, 1350-1353.
30. Kwatra M. M., Benovic J. L., Caron M. G., Lefkowitz R. J., and Hosey M. M. (1989) Phosphorylation of chick heart muscarinic cholinergic receptors by the β-adrenergic receptor kinase. Biochemistry 28, 4543-4547.
31. q/11, is a substrate of β-adrenergic receptor kinases 1 and 2. J. Biol. Chem. 268, 9161-9164.
32. Lohse M. J., Krasel C., Winstel R., and Mayor F. Jr. (1996) G-protein-coupled receptor kinases. Kidney Int. 49, 1047-1052.
33. Maldonado R., Valverde O., Garbay C., and Roques B. P. (1995) Protein kinases in the locus coeruleus and periaqueductal gray matter are involved in the expression of opiate withdrawal. Naunyn Schmiedebergs Arch. Pharmacol. 352, 565-575.
34. Matthes H. W. D., Maldonado R., Simonin F., Valverde O., Slowe S., Kitchen I., Befort K., Dierich A., Le Meur M., Dollé P., Tzavara E., Hanoune J., Roques B. P., and Kieffer B. L. (1996) Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid-receptor gene. Nature 383, 819-823.
35. 2-adrenergic receptor sequestration: intracellular complement of β-adrenergic receptor kinase and β-arrestin determine kinetics of internalization. Mol. Pharmacol. 51, 800-808.
36. Moises H. C. and Smith C.B. (1987) Changes in cortical beta-adrenergic receptor density and neuronal sensitivity to norepinephrine accompany morphine dependence and withdrawal. Brain Res. 400, 110-126.
37. Murga C., Ruiz-Gómez A., García-Higuera I., Kim C. M., Benovic J. L., and Mayor F. Jr. (1996) High affinity binding of β-adrenergic receptor kinase to microsomal membranes. J. Biol. Chem. 271, 985-994.
38. Nestler E. J. (1992) Molecular mechanisms of drug addiction. J. Neurosci. 12, 2439-2450.
39. Pei G., Kieffer B. L., Lefkowitz R. J., and Freedman N. J. (1995) Agonist-dependent phosphorylation of the mouse δ-opioid receptor: involvement of G protein-coupled receptor kinases but not protein kinase C. Mol. Pharmacol. 48, 173-177.
40. Ping R., Gelzer-Bell R., Roth D. A., Kiel D., Insel P. A., and Hammond H. K. (1995) Reduced β-adrenergic receptor activation decreases G protein expression and β-adrenergic receptor kinase activity in porcine heart. J. Clin. Invest. 95, 1271-1280.
41. Premont R. T., Inglese J., and Lefkowitz R. J. (1995) Protein kinases that phosphorylate activated G protein-coupled receptors. FASEB J. 9, 175-182.
42. Raynor K., Kong H., Mines J., Kong G., Benovic J., Yasuda K., Bell G.I., and Reisine T. (1994a) Molecular mechanisms of agonist-induced desensitization of the cloned mouse kappa opioid receptor. J. Pharmacol. Exp. Ther. 270, 1381-1386.
43. Raynor K., Kong H., Chen Y., Yasuda K., Yu L., Bell G. I., and Reisine T. (1994b) Pharmacological characterization of the cloned κ-, δ-. and μ-opioid receptors. Mol. Pharmacol. 45, 330-334.
44. Ruiz-Gómez A. and Mayor F. Jr. (1997) β-Adrenergic receptor kinase (GRK2) colocalizes with β-adrenergic receptors during agonist-induced receptor internalization. J. Biol. Chem. 272, 9601-9604.
45. Sklair-Tavron L., Shi W.-X., Lane S. B., Harris H. W., Bunney B. S., and Nestler E. J. (1996) Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons. Proc. Natl. Acad. Sci. USA 93, 11202-11207.
46. 2-adrenoceptor number and function in brains of morphine-dependent rats. Eur. J. Pharmacol. 161, 111-119.
47. Spiegel A. M., Shenker A., and Weinstein L. S. (1992) Receptor-effector coupling by G proteins: implications for normal and abnormal signal transduction. Endocr. Rev. 13, 536-565.
48. Sterne-Marr R. and Benovic J. L. (1995) Regulation of G protein-coupled receptors by receptor kinases and arrestins. Vitam. Horm. 51, 193-234.
49. Sternini C., Spann M., Anton B., Keith D. E. Jr., Bunnett N. G., von Zastrow M., Evans C., and Brecha N. C. (1996) Agonist-selective endocytosis of μ opioid receptor by neurons in vivo. Proc. Natl. Acad. Sci. USA 93, 9241-9246.
50. Terwilliger R. Z., Ortiz J., Guitart X., and Nestler E. J. (1994) Chronic morphine administration increases β-adrenergic receptor kinase (βARK) levels in the rat locus coeruleus. J. Neurochem. 63, 1983-1986.
51. Thompson R. C., Mansour A., Akil H., and Watson S. J. (1993) Cloning and pharmacological characterization of a rat μ-opioid receptor. Neuron 11, 903-913.
52. 2-adrenoceptors and μ-opioid receptor densities during morphine dependence and spontaneous withdrawal in rats. Naunyn Schmiedebergs Arch. Pharmacol. 336, 530-537.
53. Ungerer M., Parruti G., Bohm M., Puzicha M., DeBlasi A., Erdmann E., and Lohse M. J. (1994) Expression of β-arrestins and β-adrenergic receptor kinases in the failing human heart. Circ. Res. 74, 206-213.
54. Ventayol P., Busquets X., and García-Sevilla J. A. (1997) Modulation of immunoreactive protein kinase C-α and β isoforms and G proteins by acute and chronic treatments with morphine and other opiate drugs in rat brain. Naunyn Schmiedebergs Arch. Pharmacol. 355, 491-500.
55. Wang J. B., Imai Y., Eppler C. M., Gregor P., Spivak C. E., and Uhl G. R. (1993) μ-Opiate receptor: cDNA cloning and expression. Proc. Natl. Acad. Sci. USA 90, 10230-10234.
56. Young S., Parker P. J., Ullrich A., and Stabel S. (1987) Down-regulation of protein kinase C is due to an increased degradation. Biochem. J. 244, 775-779.
57. Zhang L., Yu Y., Mackin S., Weight F. F., Uhl G. R., and Wang J. B. (1996) Differential μ opiate receptor phosphorylation and desensitization induced by agonists and phorbol esters. J. Biol. Chem. 271, 11449-11454.